Pay in 4 interest-free payments of $5.80 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Tirzepatide continues to be the most prescribed anti-diabetic (ADM) and anti-obesity (AOM) medication (sold as Mounjaro and Zepbound, respectively) and showed the largest increase in total prescribing from September to December 2025
Not only did patients change what they ate, but they visited far fewer restaurants and ate less while going out
A virtual visit is required before prescribing
Always make sure you have the correct insulin before each injection
Based on application, the GLP-1 receptor agonist market is classified into obesity, type 2 diabetes mellitus, and other applications
US$ 29.03
US$ 28.68
US$ 27.81
US$ 22.35
US$ 24.60
US$ 26.06
US$ 26.41
US$ 20.76
